Logo image
Activating transcription factor 5 enhances radioresistance and malignancy in cancer cells
期刊文章

Activating transcription factor 5 enhances radioresistance and malignancy in cancer cells

Seiichiro Ishihara, Motoaki Yasuda, Akihiro Ishizu, Masayori Ishikawa, Hiroki Shirato, Hisashi Haga 和 Fang-Hsin Chen
Oncotarget, 卷.6(7), 頁碼.4602-4614
10/03/2015
PMID: 25682872
Web of Science ID: WOS:000352792000006

摘要

Cell Biology Life Sciences & Biomedicine Oncology Science & Technology
Radiotherapy is effective for treating various types of tumors. However, some cancer cells survive after irradiation and repopulate tumors with highly malignant phenotypes that correlate with poor prognosis. It is not known how cancer cells survive and generate malignant tumors after irradiation. Here, we show that activating transcription factor 5 (ATF5) promotes radioresistance and malignancy in cancer cells after irradiation. In the G1-S phase of the cell cycle, cancer cells express high levels of ATF5, which promotes cell cycle progression and thereby increases radioresistance. Furthermore, ATF5 increases malignant phenotypes, such as cell growth and invasiveness, in cancer cells in vitro and in vivo. We have identified a new mechanism for the regeneration of highly malignant tumors after irradiation and shown that ATF5 plays a key role in the process.

檔案與連結 (1)

url
https://doi.org/10.18632/oncotarget.2912檢視
已出版(紀錄版本) 開放

相關連結

詳細資料

Logo image